Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dardano

Showing results (1-10 of 59) with videos related to

Pageof 6
Sort By:
Treatments in Endocrinology|March 18, 2006
Does treating subclinical hypothyroidism improve markers of cardiovascular risk?Fabio Monzani, Angela Dardano, Nadia Caraccio
Nutrients|August 28, 2025
Is It Worth Assessing the Prevalence of Sarcopenia in Pregnant Women? Should Any Impact on Pregnancy Outcomes Be Expected?Christian Göbl, Angela Dardano, Giuseppe Daniele, et al.
Vascular Health and Risk Management|August 22, 2014
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetesAngela Dardano, Cristina Bianchi, Stefano Del Prato, et al.
Aging|April 23, 2014
Optimal therapy of type 2 diabetes: a controversial challengeAngela Dardano, Giuseppe Penno, Stefano Del Prato, et al.
Atherosclerosis|April 30, 2024
The current landscape for diabetes treatment: Preventing diabetes-associated CV riskAngela Dardano, Cristina Bianchi, Monia Garofolo, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2015
New forms of insulin and insulin therapies for the treatment of type 2 diabetesAvivit Cahn, Roberto Miccoli, Angela Dardano, et al.
BMJ Open|March 2, 2026
Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D studyAngela Dardano, Giuseppe Daniele, Christian S Göbl, et al.
Acta Diabetologica|May 29, 2012
Adipocytokines mark insulin sensitivity in euthyroid Hashimoto's patientsAnna Solini, Angela Dardano, Eleonora Santini, et al.
Nutrients|March 26, 2022
Effects of Intermittent Fasting on Brain MetabolismAlex Brocchi, Eleni Rebelos, Angela Dardano, et al.
Frontiers in Endocrinology|March 17, 2022
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case ReportAngela Dardano, Michele Aragona, Giuseppe Daniele, et al.
Pageof 6

Showing results (1-10 of 59) with videos related to

Sort By:
Pageof 6
Treatments in Endocrinology|March 18, 2006
Does treating subclinical hypothyroidism improve markers of cardiovascular risk?Fabio Monzani, Angela Dardano, Nadia Caraccio
Nutrients|August 28, 2025
Is It Worth Assessing the Prevalence of Sarcopenia in Pregnant Women? Should Any Impact on Pregnancy Outcomes Be Expected?Christian Göbl, Angela Dardano, Giuseppe Daniele, et al.
Vascular Health and Risk Management|August 22, 2014
Insulin degludec/insulin aspart combination for the treatment of type 1 and type 2 diabetesAngela Dardano, Cristina Bianchi, Stefano Del Prato, et al.
Aging|April 23, 2014
Optimal therapy of type 2 diabetes: a controversial challengeAngela Dardano, Giuseppe Penno, Stefano Del Prato, et al.
Atherosclerosis|April 30, 2024
The current landscape for diabetes treatment: Preventing diabetes-associated CV riskAngela Dardano, Cristina Bianchi, Monia Garofolo, et al.
The Lancet. Diabetes & Endocrinology|June 9, 2015
New forms of insulin and insulin therapies for the treatment of type 2 diabetesAvivit Cahn, Roberto Miccoli, Angela Dardano, et al.
BMJ Open|March 2, 2026
Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D studyAngela Dardano, Giuseppe Daniele, Christian S Göbl, et al.
Acta Diabetologica|May 29, 2012
Adipocytokines mark insulin sensitivity in euthyroid Hashimoto's patientsAnna Solini, Angela Dardano, Eleonora Santini, et al.
Nutrients|March 26, 2022
Effects of Intermittent Fasting on Brain MetabolismAlex Brocchi, Eleni Rebelos, Angela Dardano, et al.
Frontiers in Endocrinology|March 17, 2022
Efficacy of Dulaglutide in a Patient With Type 2 Diabetes, High Cardiovascular Risk, and HIV: A Case ReportAngela Dardano, Michele Aragona, Giuseppe Daniele, et al.
Pageof 6